Focus on US FDA

Issue Date: November 2008

Inside:
FDA: playing by its own rules? - The US FDA has recently urged a number of companies to amend approved labeling to include warnings that did not meet the legal standard established in its own regulations. Sheldon Bradshaw and Kyle Sampson question whether FDA practice is undermining its position in the timely case of Wyeth v. Levine

Drug Delivery 2008

Issue Date: November 2008

Inside:
Number crunching for engineers, Big pharma's wish list and the importance of diligence

Focus on Regulatory Affairs

Issue Date: September 2008

Inside:
Advanced thinking - New regulation set to come into effect across the EU this December aims to provide much needed charity for the increasingly complex area of advanced therapies. Anthony Warnock Smith and Natalie Kingston explain what it invloves

Focus on Pharmaceutical Sales

Issue Date: September 2008

Inside:
Section 1 - Dodging the bullet - Pharmaceutical and biotech companies are particularly vulnerable to accusations of bribery and corruption. Marc Dalby explains how charges can be averted through a few simple routines. Section 2 - Optimising the message and messenger - Broad industry pressures have changed the nature of the key physician/sales rep relationship. David Owen provides insights from new market research that set the stage for more effective sales calls

Your Career in Pharma

Issue Date: September 2008

Inside:
The choosy candidate, Can translational medicine deliver? and MHRA in the frame

CPhI Preview 2008

Issue Date: August 2008

Inside:
Official show preview - covers CPhI Worldwide, ICSE & P-MEC

Focus on Controlled-Release Therapies

Issue Date: July 2008

Inside:
New life from controlled-release - With days to go before the 35th Annual Meeting of the Controlled Release Society, Tom Moberly looks at the latest developments in one of the most vibrant sectors in pharmaceutical research

Head to Head

Issue Date: June 2008

Inside:
How can the pharma industry recapture its innovative edge?

Focus on Patient Recruitment

Issue Date: June 2008

Inside:
First things first - A new study has found that the increasing complexity of clinical trial protocols has had a significant detrimental impact on patient recruitment and retention rates. Therefore, sponsors need to look at their protocols first if they are to overcome bottlenecks in these areas, says Ken Getz

Guide to UK Biopharma

Issue Date: June 2008

Inside:
NHS & industry: overcoming their differences, London: top spot for IPOs and Filling the talent gap

DIA Annual Meeting 2008

Issue Date: May 2008

Inside:
Boston: The importance of place, The new clinical researchers and Discussing the big issues

Focus on Oncology

Issue Date: May 2008

Inside:
Cancer drugs - the economic challenge. Karol Sikora assesses the extent to which health technology assessments, the ageing population and societal changes will influence the future of cancer care

Contract Research Update

Issue Date: April 2008

Inside:
CROs under scrutiny and ACRO: the voice of the industry

Focus on Pharmaceutical Manufacturing

Issue Date: March 2008

Inside:
Unleashing value from green initiatives - Dr Geoff Leaver explains how chemical and pharmaceutical companies are enjoying imrpoved environmental performance and reduced costs through implementation of resource-efficient practices

DIA EuroMeeting 2008

Issue Date: March 2008

Inside:
A new face and a fresh approach at DIA, Discussing the future of healthcare and Where to go, what to say in Barcelona

Focus on Pharmaceutical Ingredients

Issue Date: January 2008

Inside:
Can Asia innovate? - Dr Rob Bryant discusses whether cultural norms are holding back Asian fine chemical companies